- Liquid-Based Needle Free Injectors
- Projectile/Depot-Based Needle-Free Injectors
- Powder-Based Needle Free Injectors
Needle Free Injection Market size was valued at USD 125 million in 2022 and is poised to grow at a CAGR of 17.2% from 2023-29. Due to the increase in prevalence of various types of chronic diseases such as cancer, diabetes and so on, risk of exposure to communicable diseases due to needle stick injuries, and decrease in healthcare costs. Moreover, the advantage of painlessness, the wide range of applications with the needle-free injection, and the rise in R&D activities for the development of needle-free injections are the major factors that are driving the growth of the global market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global needle free injection products.
Study Period
2024-2030Base Year
2023CAGR
17.2%Largest Market
North AmericaFastest Growing Market
Europe
Increase in the prevalence of cancer, diabetes, and infectious diseases is a key factor drive the global needle free injection market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe and approximately 422 Mn people are suffering from diabetes all over the world. Moreover, the raise in funding for the R&D activities by public and private sectors and the wide range of applications and advantages are anticipated to propel the global needle free injection market over the forecast years.
By Type of Medication
By Product
By Application
By End User
The needle free injection market size was valued at USD 125 million in 2022
The needle-free injection market: Antares Pharma, (U.S.) Crossject needle-free injection systems ( France) DAntonio Consultants International Inc. (U.S.) European Pharma Group (Netherlands) Endo Pharmaceuticals Inc. (Ireland) INJEX Pharma GmBH. (Germany) Medical International Technology, Inc., (Canada) National Medical Products Inc., (Saudi Arabia) Mika Medical Co., (Korea) PenJet Corporation. (U.S.)
The needle-free injection market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Table of Content
19. Research Methodology
20. Key Assumptions and Acronyms